Skip to content

Retrospective study to evaluate the recurrence rate depending on the surgical procedure in patients with tenosynovial giant cell tumour (pigmented villonodular synovitis).The clinical parameters, such as the course and extent of the disease, the therapy and any local recurrence or progression of the disease are recorded.

Retrospective study to evaluate the recurrence rate depending on the surgical procedure in patients with tenosynovial giant cell tumour (pigmented villonodular synovitis).The clinical parameters, such as the course and extent of the disease, the therapy and any local recurrence or progression of the disease are recorded. - TGCT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035455
Enrollment
700
Registered
2024-11-22
Start date
2019-01-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M12

Interventions

Group 1: The clinical symptoms of the patients are evaluated according to the course of the file, as well as local imaging (MRI) at the same intervals as during the clinical check-ups.

Sponsors

LMU Klinikum
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients with a tenosynovial giant cell tumour who undergo surgery at the study centre during the study period will be included.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Local recurrence rate or progression of the disease. This is determined at the time of the final study evaluation using the last available MRI.

Secondary

MeasureTime frame
Progression-free survival

Countries

Germany

Contacts

Public ContactHans Roland Dürr

LMU Klinikum

hans_roland.duerr@med.uni-muenchen.de+4989440076782

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026